US SB1936

Requires the Center for Medicare and Medicaid Innovation (CMI) to establish within 1 year a model testing separate payment for blood transfusions for hospice patients, rather than including them in the all-inclusive per diem hospice rate

Separate transfusion payments would be calculated at the same rate as if the transfusion were furnished outside of hospice care under Medicare

Mandates CMI evaluation comparing model participants to similar non-participating patients on metrics including chemotherapy services in the last 14 days of life and hospital utilization in the last 30 days of life

Evaluation must also measure days receiving hospice care before end of life, transfusion frequency, and total number of transfusions for hospice versus non-hospice patients with similar diagnoses

Introduced June 3, 2025 by Senators Rosen (D-NV), Barrasso (R-WY), and Baldwin (D-WI); referred to Senate Finance Committee